-
31 Oct 2017
-
26 Oct 2017
-
18 Oct 2017
Together, we are strong enough to stop MS
- 2 days 6 hours ago.
- 3 days 11 hours ago.
- 4 days 8 hours ago.
- Ocrelizumab has been recommended for a licence as the first treatment for primary progressive #MS across Europe:… t.co/7Mmvjitwyz
- We want to make sure everyone with #MS is getting the best care. The European Academy of Neurology (EAN) is develop… t.co/xr8Xjw1PHJ
- #FridayFeeling We asked people living with #MS to share their top 5 tips for wellbeing: t.co/1bbbXAIotE t.co/fcWCJCGZ2Q


.jpg)



